FUNCTION OF GUT PEPTIDES ISOLATED GUT MUSCLE CELLS
Project Number5R01DK028300-07
Contact PI/Project LeaderMAKHLOUF, GABRIEL M.
Awardee OrganizationVIRGINIA COMMONWEALTH UNIVERSITY
Description
Abstract Text
The objective of this proposal is to characterize the properties of smooth
muscle cells isolated from the mammalian gut. We have developed techniques for
isolation of muscle cells from the stomach (guinea pig, dog and man) and
gallbladder (dog and man) and have devised an image-splitting micrometric
technique for the direct measurement of contraction and relaxation. We have
also applied techniques for the indirect measurement of muscle cell response in
terms of cellular intermediates: intracellular levels of cyclic nucleotides;
45Ca ions efflux and the phosphorylated fraction of myosin light chain (using
IEF/SDS electrophoresis). The specific aims of the proposal are: 1) to identify
and characterize smooth muscle receptors for gut peptides; these are known to be
present in nerve fibers of the submucous and myenteric plexuses of the gut and
are thought to play a physiological role as neurotransmitters or neuromodulators
in the control of smooth muscle activity; the most likely candidates are VIP,
the opioid peptides (met- and leu-enkephalin), substance P and bombesin.
2) To define the contractile response to peptides by measurement of 45Ca ions
efflux and the phosphorylated fraction of myosin light chain, and 3) To define
the role of cyclic AMP in smooth muscle relaxation induced by VIP and its
homologues and test the possibility that ATP (the putative 'purinergic' relaxant
neurotransmitter) and VIP interact synergistically to modulate neurally-induced
relaxation.
National Institute of Diabetes and Digestive and Kidney Diseases
CFDA Code
DUNS Number
105300446
UEI
MLQFL4JSSAA9
Project Start Date
01-April-1984
Project End Date
31-March-1989
Budget Start Date
01-April-1987
Budget End Date
31-March-1988
Project Funding Information for 1987
Total Funding
$102,285
Direct Costs
$68,190
Indirect Costs
$34,095
Year
Funding IC
FY Total Cost by IC
1987
National Institute of Diabetes and Digestive and Kidney Diseases
$102,285
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 5R01DK028300-07
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 5R01DK028300-07
Patents
No Patents information available for 5R01DK028300-07
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 5R01DK028300-07
Clinical Studies
No Clinical Studies information available for 5R01DK028300-07
News and More
Related News Releases
No news release information available for 5R01DK028300-07
History
No Historical information available for 5R01DK028300-07
Similar Projects
No Similar Projects information available for 5R01DK028300-07